Ligand validation:4UO1

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 4UO1 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4UO1_NAG_E_441	22%	60%	0.255	0.869	0.52	1	-	1	0	0	100%	0.9333
4UO1_NAG_C_631	18%	42%	0.229	0.824	0.62	1.62	-	3	0	0	93%	0.9333
4UO1_NAG_C_632	17%	58%	0.24	0.828	0.6	1	-	1	0	0	93%	0.9333
4UO1_NAG_A_411	13%	63%	0.32	0.868	0.54	0.87	-	-	0	0	100%	0.9333
4UO1_NAG_D_201	12%	52%	0.304	0.836	0.65	1.18	-	2	0	0	100%	0.9333
4UO1_NAG_E_621	1%	47%	0.453	0.65	0.68	1.34	-	1	0	0	100%	0.9333
4UO1_NAG_D_202	0%	69%	0.56	0.627	0.54	0.67	-	-	0	0	93%	0.9333
4UO7_NAG_C_601	28%	35%	0.208	0.858	0.42	2.08	-	1	0	0	100%	0.9333
4UO3_NAG_C_451	27%	38%	0.187	0.836	0.64	1.75	-	2	2	0	100%	0.9333
4UO6_NAG_A_641	27%	55%	0.24	0.886	0.72	1.02	-	2	0	0	100%	0.9333
4UO2_NAG_A_411	12%	51%	0.306	0.842	0.55	1.31	-	2	0	0	100%	0.9333
4UO8_NAG_A_601	11%	48%	0.277	0.79	0.52	1.48	-	3	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3PPS_NAG_B_760	100%	44%	0.028	0.993	0.57	1.57	-	3	0	0	100%	0.9333
5O59_NAG_A_601	100%	70%	0.024	0.993	0.3	0.85	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.